Bioprocess Insider recent news | BioProcess International
网页Sep 23 - Sep 26, 2024. Sep 23 - Sep 26, 2024. Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Learn More.
Cell-Line Engineering and Development - BioProcess International
网页Cheryl Scott is cofounder and senior technical editor of BioProcess. International, part of Informa Connect; 1-212-600-3429; cheryl. [email protected]. REGISTER TO DOWNLOAD. Critical to the manufacturing of biotherapeutics is development of robust and stable cell-line engineering that expresses high-quality products in large quantities.
DNA Vaccines Prepare for Commercial Debut - BioProcess …
网页Five main approaches have emerged in the first flush of COVID-19 vaccine development: viral vectors, protein subunits, inactivated viruses, attenuated viruses, and nucleic acids. Our technologies belong in the DNA vaccine segment of the nucleic-acid category. The frontrunner among DNA-based SARS-CoV-2 vaccines is Inovio’s INO-4800 candidate.
Recent publications | page 1 of 13 | BioProcess International
网页Sep 23 - Sep 26, 2024. Sep 23 - Sep 26, 2024. Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Learn More.
Sterilizing-Grade Filtration of Liposomes Using 3D Imaging
网页Sterilizing-grade filtration is an essential operation for biomanufacturing. It ensures that drug substances are free from microorganisms at the end of a downstream process. The COVID-19 pandemic has highlighted the need for high-quality therapies to be manufactured efficiently at scale, with particular focus on the need for multiple vaccines ...
Total Global Capacity Finally Shows Improved Productivity
网页Since 2018, global bioprocessing capacity has grown from 16.5 million liters (1) to 17.4 million liters. Although output has continued to expand at around 12% overall, that rate represents a significant slowing in capacity growth as the industry moves toward greater productivity and efficiency. Trends that we have tracked in the BioPlan ...
Use of Digital Twins in Biopharmaceutical Pathogen Safety Testing ...
网页2021年12月14日 — In the context of biopharmaceutical process development, digital twins can help streamline and accelerate experiments associated with product commercialization. From an industry perspective, the possibility of reducing the number of time- and resource-intensive wet-laboratory experiments serves as a strong business driver.
Viral Clearance recent news | BioProcess International
网页A Challenge in Viral Clearance Determination: Estimation of Fifty-Percent Tissue Culture Infective Dose (TCID50) for Low Virus Concentrations. May 24, 2020. by Anne Charlotte Arentsen, Søren Kamstrup. Viral Clearance.
Drivers, Opportunities, and Limits of Continuous Processing
网页2017年3月20日 — REGISTER TO DOWNLOAD. Figure 1: Drivers of continuous processing success. Biologics represent a significant group of approved drugs, and they are expected to continue their exceptional growth in the foreseeable future. At first glance, innovative monoclonal antibodies (MAbs) and their derivatives seem to dominate the field; however, …
Medium and Process Optimization for High Yield, High Density …
网页2009年2月1日 — The most important contributions to high-yield manufacturing processes for the production of recombinant proteins from cultivated mammalian cells have come from the identification of highly enriched and well-balanced media formulations, and fine tuning the process conditions that support high cell culture densities with high specific productivity.